Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases

Tissue fibrosis is a key factor leading to disability and death worldwide; however, thus far, there are no approved treatments for fibrosis. Transforming growth factor (TGF)-β is a major pro-fibrotic cytokine, which is expected to become a target in the treatment of fibrosis; however, since TGF-β ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ning, Wang, Zhihong, Zhu, Hecheng, Liu, Weidong, Zhao, Ming, Jiang, Xingjun, Zhao, Jin, Ren, Caiping, Zhang, Yan, Luo, Longlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197809/
https://www.ncbi.nlm.nih.gov/pubmed/35147920
http://dx.doi.org/10.1007/s12026-022-09267-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197809/
https://www.ncbi.nlm.nih.gov/pubmed/35147920
http://dx.doi.org/10.1007/s12026-022-09267-y

Ejemplares similares